Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

It is well recognized that aging in men is accompanied by a decline in the serum levels of some adrenal and testicular steroids, but little or no attention has focused on the multiple steroid metabolites that are formed by steroid-converting enzymes in target tissues. In the present study, we have examined in detail the serum concentrations of a large series of adrenal and testicular steroids and their most significant metabolites produced in intracrine peripheral tissues. The serum concentrations of 26 conjugated and unconjugated C21-, C19-, and C18-steroids were measured in 2423 men aged 40-80 yr. The serum concentrations of the major circulating adrenal C19-steroids, namely dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S), androst-5-ene-3 beta, 17 beta-diol and its sulfate, and androstenedione, decreased by about 60% between the ages of 40-80 yr. The small decrease in the serum concentrations of progesterone and pregnenolone in the presence of increased levels of cortisol and markedly decreased levels of DHEA, androst-5-ene-3 beta, 17 beta-diol, and their polar metabolites suggests that adrenal 17,20-lyase is particularly affected by aging. In addition to a marked decline in the serum concentrations of adrenal C19-steroids, a smaller, but significant, decrease occurred in serum testosterone. However, serum dihydrotestosterone levels remained constant, but the glucuronidated derivatives of dihydrotestosterone metabolites (androstane-3 alpha, 17 beta-diol glucuronide, androstane-3 beta, 17 beta-diol glucuronide, and androsterone glucuronide) were reduced by 45-50%, suggesting that 5 alpha-reductase activity in peripheral tissues may show a compensatory increase during aging. Analysis of the fatty acid esters of DHEA (DHEA-FA) also revealed that these nonpolar steroids markedly decrease between 40-80 yr of age, although such a decrease in DHEA-FA levels was smaller than that in DHEA and DHEA-S, suggesting that the formation of DHEA-FA may be specifically increased during aging. In summary, the present study suggests that in contrast to the marked decline in activity of steroidogenic enzymes in the adrenals and the small decrease in the testis, the activity of the steroid-converting enzymes present in peripheral tissues does not decrease during aging. In fact, the marked decrease in DHEA formation by the adrenals leads to a decrease of about 50% in total androgens in men between the ages of 40-80 yr. Such a decrease probably affects many physiological processes during aging.

[1]  F. Labrie,et al.  Steroid glucuronides: Human circulatory levels and formation by LNCaP cells , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  R. Horton,et al.  Origin of plasma androstanediol glucuronide in men. , 1984, The Journal of clinical endocrinology and metabolism.

[3]  M. Takahashi,et al.  Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  R. Barbieri,et al.  Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men. , 1992, The Journal of clinical endocrinology and metabolism.

[5]  F. Labrie,et al.  Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. , 1987, Journal of steroid biochemistry.

[6]  L. Dogliotti,et al.  Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. , 1990, European journal of cancer.

[7]  J. Nyce,et al.  Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. , 1988, Advances in cancer research.

[8]  D Rodbard,et al.  Computer analysis of radioligand assay and radioimmunoassay data. , 1970, Acta endocrinologica. Supplementum.

[9]  J. Sulon,et al.  Adrenal circadian system in young and elderly human subjects: a comparative study. , 1982, The Journal of endocrinology.

[10]  E. Barrett-Connor,et al.  A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. , 1986, The New England journal of medicine.

[11]  A. Bélanger,et al.  Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. , 1986, The Journal of clinical endocrinology and metabolism.

[12]  P. Wahl,et al.  Population-based reference values for lecithin-cholesterol acyltransferase (LCAT). , 1982, Atherosclerosis.

[13]  J. Simard,et al.  Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  G. Chrousos,et al.  Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. , 1986, The Journal of clinical endocrinology and metabolism.

[15]  F. Labrie,et al.  Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer. , 1984, The Journal of clinical endocrinology and metabolism.

[16]  S. Yen,et al.  Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. , 1990, The Journal of clinical endocrinology and metabolism.

[17]  A. Bélanger,et al.  Pregnenolone fatty acid esters incorporated into lipoproteins: substrates in adrenal steroidogenesis. , 1992, Endocrinology.

[18]  C. Spicer,et al.  Abnormal excretion of urinary steroids by women with early breast cancer. , 1962, Lancet.

[19]  J. Simard,et al.  Structure and Expression of a New Complementary DNA Encoding the almost Exclusive 3β-Hydroxysteroid Dehydrogenase/Δ5-Δ4-lsomerase in Human Adrenals and Gonads , 1991 .

[20]  C. Labrie,et al.  Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. , 1988, Endocrinology.

[21]  J. Clore,et al.  Metabolism and actions of dehydroepiandrosterone in humans , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  N. Orentreich,et al.  Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.

[23]  R. Tremblay,et al.  Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. , 1987, Fertility and sterility.

[24]  J. Mckinlay,et al.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. , 1991, The Journal of clinical endocrinology and metabolism.

[25]  S. Pang,et al.  3α-Androstanediol Glucuronide in Virilizing Congenital Adrenal Hyperplasia: A Useful Serum Metabolic Marker of Integrated Adrenal Androgen Secretion , 1991 .

[26]  A. Vermeulen Clinical review 24: Androgens in the aging male. , 1991, The Journal of clinical endocrinology and metabolism.